Judge Says Pharma Industry Has 'Perverted' Hatch-Waxman
A Delaware federal judge has refused to further support his finding that a patent on bladder medication Myrbetriq is ineligible for patent protection as owner Astellas Pharma and various generic-drug makers...To view the full article, register now.
Already a subscriber? Click here to view full article